Artemis Global Life Sciences Limited

Equities

AGLSL

INE517U01013

End-of-day quote NSE India S.E. Other stock markets			5-day change	1st Jan Change
- ^INR	-.--%		-.--%	-.--%

2019	Artemis Global Life Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	CI
2019	Artemis Global Life Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2019	CI

Artemis Global Life Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2019

May 09, 2019 at 10:43 am EDT

Artemis Global Life Sciences Limited announced earnings results for the full year ended March 31, 2019. For the full year, the company announced operating income - ar was INR 0. Net income was INR 203.886 million. Basic earnings per share was INR 3.1.

Latest news about Artemis Global Life Sciences Limited

Artemis Global Life Sciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2019	19-08-13	CI
Artemis Global Life Sciences Limited Reports Earnings Results for the Full Year Ended March 31, 2019	19-05-09	CI
Artemis Global Life Sciences Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019	19-05-09	CI
Artemis Global Life Sciences Limited Reports Earnings Results for the Third Quarter Ended December 31, 2018	19-02-04	CI
Artemis Global Life Sciences Limited Announces Unaudited Standalone and Consolidated Earnings Results for the Second Quarter and Six Months Ended September 30, 2018	18-11-12	CI
Artemis Global Life Sciences Limited Reports Audited Consolidated and Standalone and Earnings Results for the Year Ended March 31, 2018	18-08-20	CI
Artemis Global Life Sciences Limited Announces Unaudited Standalone and Consolidated Earnings Results for First Quarter Ended June 30, 2018	18-08-03	CI
Artemis Global Life Sciences Limited Announces Audited Standalone Earnings Results for the Fourth Quarter and Full Year and Consolidated Earnings Results for the Year Ended March 31, 2018	18-05-09	CI
Artemis Global Life Sciences Limited Announces Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2017	18-02-05	CI
Artemis Global Life Sciences Limited Announces Unaudited Standalone Earnings Results for the Second Quarter and Six Months Ended September 30, 2017	17-10-31	CI
Artemis Global Life Sciences Limited Announces Management Appointments	17-09-27	CI
Artemis Global Life Sciences Limited Announces Unaudited Standalone Earnings Results for the First Quarter Ended June 30, 2017	17-08-04	CI
Artemis Global Life Sciences Limited Announces Management Appointments	17-08-04	CI
Enterprises Ltd. completed the spin-off Artemis Global Life Sciences Ltd. (‘AGLS’) for INR 9.3 billion.	17-03-29	CI
The Board of PTL Enterprises Ltd. entered into a scheme of arrangement to spin-off Artemis Global Life Sciences Ltd.	16-02-01	CI
PTL Enterprises To Divest Athena Eduspark	14-05-06	CI
PTL Enterprises Seeks To Sell PTL Projects	14-02-12	CI

Chart Artemis Global Life Sciences Limited

Duration

Period

Chart Artemis Global Life Sciences Limited

More charts

Company Profile

Artemis Global Life Sciences Limited is an India-based company engaged in the business of buying, selling, managing, improving, maintaining, taking on lease, promoting, administer, own or run hospitals, clinics, nursing homes, dispensaries. It is also engaged in the business of maternity homes, old age homes, health resorts and health clubs, polyclinics, medical centers, child welfare and family planning centers, diagnostic centers. The Company is also into all types of laboratories for carrying on investigation, x-ray, CAT scan, ECG and medical research and provision of all kinds of medical and health services and equipments. The objective of the Company is to buy, sell, manufacture or deal in all type of drugs, medicines including alternative/Ayurveda medicines pharmaceuticals, chemicals and colors used in drugs, medicines and pharmaceuticals and in their raw materials.

Sector

More about the company